AMSBIO introduces ALiCE® - a new high yield cell-free protein expression system.
Cell-free protein expression (CFPE) is today used by protein chemists to quickly produce small amounts of proteins when screening DNA libraries. However current technologies are limited and there is a need for higher protein expression yields.
ALiCE® is a unique eukaryotic system, which yields an unprecedented 3 mg/ml of protein in batch mode. Even prokaryotic systems, which generally can only handle easy-to-express proteins, only get at their best 1 mg/ml protein in batch mode.
These higher…
PRINCETON, NJ – Nov. 28, 2018 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in greater likelihood of trial success. By allowing users to model and simulate different clinical trial scenarios, Certara’s Trial Simulator® allows them to identify and assess risks and preview the range of expected results before millions of R&D dollars are spent and human subjects are exposed to…
LOUGHBOROUGH, England (Nov. 26, 2018) – Activate Science, an annual event series organised by Thermo Fisher Scientific and attended by laboratory personnel across Europe, reached delegates at 36 customer sites in 2018.
Emily Quinton, European Marketing Communications Manager, commented: “Activate Science has reached nearly 3,300 delegates in 10 European countries this year and provides a valuable opportunity to network and experience the latest innovations in laboratory products hands-on at customer sites.”
Activate Science events are aimed at all laboratory personnel, including anyone who…
Air Liquide is pleased to announce their new site at Waterbeach in Cambridge.
In order to get closer to our customers and provide the service you require we are now closer than ever to your business.
- Expert support in Speciality and Industrial gas applications
- Fast delivery from stock
- All ranges of equipment and design assistance
Email: john.pritchard@airliquide.com
Tel: 07970 234332
Contact us to find out more: uk-sg-sales@airliquide.com
0845 757 3143
Listening to you, Working with you, Supporting you, GROWING TOGETHER.
AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.Appearing at the Wellcome Genome Campus (Cambridge), the MRC Centre for Regenerative Medicine (Edinburgh) and at Guys Hospital (London) - Dr Nakagawa will present a talk on how to obtain well-reprogrammed and uniform human iPSCs using a combination of efficient reprogramming systems with a …
Acquisition increases BioIVT’s supply of leukopaks, plasma and sera, and enhances its ability to support the in vitro diagnostic market
Westbury, NY – Nov. 5, 2018 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community for more than 37 years. BSC is headquartered in Colmar, PA, with two additional FDA-registered donor centers in Allentown, PA and Reading, PA.
“We are delighted that BSC…
Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28th & 29th November at the Belfry Hotel, Nottingham.
This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry.
The conference programme will include the following topics among others:
• Water system biofilms
• Uses and applications of microbiological culture media
• Sterility assurance strategies
• Aseptic manufacturing
• Endotoxin testing
• Fungal and bacterial cleanroom excursions
•…
WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 30, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 26 scientific posters, both independently and collaboratively with clients, at Neuroscience 2018, the 48th annual meeting of the Society for Neuroscience (SfN). The meeting, which brings together more than 30,000 researchers from 80 countries, will take place from November 3-7, in San Diego, California.
Continued Commitment to Scientific Excellence
Throughout the…
WILMINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Oct. 25, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimization of antibody discovery platforms.
This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20181025005076/en/
This partnership will grant Charles River’s clients access to Distributed Bio’s antibody libraries and integrated antibody optimization…
Cambridge, UK., 30th October 2018: Arecor Ltd (“the Company”), the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals via the innovative reformulation of proteins and peptides, continues to build a strong patent portfolio protecting the Company’s proprietary technology and product assets.
Arecor is pleased to announce the successful outcome of the opposition proceedings at the European Patent Office in relation to a key patent of the Company’s broad portfolio that leads to the prevention of aggregation of therapeutic proteins during…